Back
Geron 10K Form
Sell
27
GERN
Geron
Last Price:
3.77
Seasonality Move:
10.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | GERN/Geron Quarterly |
| 2023-11-02 | 10Q | GERN/Geron Quarterly |
| 2023-08-03 | 10Q | GERN/Geron Quarterly |
| 2023-05-11 | 10Q | GERN/Geron Quarterly |
| 2022-11-07 | 10Q | GERN/Geron Quarterly |
| 2022-08-11 | 10Q | GERN/Geron Quarterly |
Receive GERN News And Ratings
See the #1 stock for the next 7 days that we like better than GERN
GERN Financial Statistics
Sales & Book Value
| Annual Sales: | $237K |
|---|---|
| Cash Flow: | $-58.94M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.48 |
| Price / Book: | 7.57 |
Profitability
| EPS (TTM): | -0.32000 |
|---|---|
| Net Income (TTM): | $-201.19M |
| Gross Margin: | $0 |
| Return on Equity: | -67.86% |
| Return on Assets: | -46.07% |
Geron Earnings Forecast
Key Geron Financial Ratios
- The Gross Profit Margin over the past 21 years for GERN is 0.00%.
- The Selling, General & Administrative Expenses for GERN have been equal to 29,170.89% of Gross Profit Margin.
- The Research & Development expenses have been 52,762.03% of Revenue.
- The Interest Expense is -4.51% of Operating Income.
- The Net Earning history of GERN is -77,690.72% of Total Revenues.
- Per Share Earnings over the last 28 years have been positive in 16 years.
Geron Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GERN |
| CUSIP: | 374163 |
| Website: | geron.com |
Debt
| Debt-to-Equity Ratio: | 0.29 |
|---|---|
| Current Ratio: | 2.89 |
| Quick Ratio: | 2.68 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |